Qureight raised $20M Series B to accelerate development of AI disease models and expand its imaging analytics platform for clinical trials.
- Amount
- $20M
- Stage
- Series B
- Announced
- 24 July 2026
- Lead
- Molten Ventures
- Other investors
- Hargreave Hale AIM VCT, XTX Ventures, Guinness Ventures, Meltwind, Ascension
- Use of funds
- Build an AI imaging laboratory, develop new disease models in asthma, pulmonary hypertension and bronchiectasis, and grow commercial operations.
- Total raised
- $30.7M to date
- Checked
- Amount and date checked against the press source